期刊
SMALL METHODS
卷 5, 期 7, 页码 -出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/smtd.202100071
关键词
adoptive cell therapy; CAR; CRISPR/Cas9; genome targeting; nonviral methods; size-reduced plasmid
资金
- Zhejiang Provincial Key Laboratory of Immunity and Inflammatory diseases - National Natural Science Foundation of China [31971324, 31971125]
- Zhejiang Provincial Natural Science Foundation [LR20H160003]
Genome editing of T cells using modified plasmid DNA can simplify and expedite the process of producing CAR-T cells, increasing their potency for research and clinical purposes.
T cell genome editing holds great promise to advance a range of immunotherapies but is encumbered by the dependence on difficult-to-produce and expensive viral vectors. Here, small double-stranded plasmid DNA modified to mediate high-efficiency homologous recombination is designed. The resulting chimeric antigen receptor (CAR)-T cells display a similar phenotype, transcriptional profile, and in vivo potency to CAR-T cells generated using adeno-associated viral vector. This method should simplify and accelerate the use of precision engineering to produce edited T cells for research and clinical purposes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据